PDF herunterladen
CC BY-NC-ND 4.0 · World J Nucl Med 2022; 21(04): 267-275
DOI: 10.1055/s-0042-1750013
Original Article

Assessment of Alzheimer's Disease Imaging Biomarkers in World Trade Center Responders with Cognitive Impairment at Midlife

Minos Kritikos
1   Department of Family, Population, and Preventive Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Ana M. Franceschi
2   Division of Neuroradiology, Department of Radiology, Northwell Health/Donald and Barbara Zucker School of Medicine, Manhasset, New York, United States
,
Paul Vaska
3   Department of Radiology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Sean A. P. Clouston
1   Department of Family, Population, and Preventive Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Chuan Huang
3   Department of Radiology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
4   Department of Psychiatry, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Michael Salerno
3   Department of Radiology, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Yael Deri
5   Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Cheuk Tang
6   Icahn School of Medicine at Mount Sinai, New York, New York, United States
,
Alison Pellecchia
5   Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Stephanie Santiago-Michels
5   Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Mary Sano
7   Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, United States
,
Evelyn J. Bromet
5   Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
,
Roberto G. Lucchini
8   Robert Stempel College of Public Health and Social Work, Florida International University, Miami, Florida, United States
,
Sam Gandy
7   Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, United States
9   Department of Neurology, The Barbara and Maurice Deane Center for Wellness and Cognitive Health and the Mount Sinai Center for NFL Neurological Care, Icahn School of Medicine at Mount Sinai, New York, New York, United States
,
Benjamin J. Luft
5   Department of Medicine, Renaissance School of Medicine at Stony Brook University, Stony Brook, New York, United States
10   Stony Brook World Trade Center Wellness Program, Stony Brook Medicine, Stony Brook, New York, United States
› Institutsangaben Funding Funding to study aging in World Trade Center (WTC) responders was provided by the National Institutes of Health (NIH/NIA: R01 AG049953). Funding for the amyloid imaging study was provided by the Centers for Disease Control and Prevention (CDC/NIOSH: U01 OH011314) while funding for the WTC responder monitoring program was provided by the Centers for Disease Control and Prevention (CDC/NIOSH: 200–2011–39361). The brain imaging program at The Barbara and Maurice Deane Center for Wellness and Cognitive Health and the Mount Sinai Center for NFL Neurological Care acknowledges the support of the Alzheimer's Drug Discovery Foundation. We would like to acknowledge and kindly thank the participants in this study and Ms. Melissa Carr7 for her supervision and coordination of participant recruitment.
› Weitere Informationen
Auch verfügbar auf
   Lizenzen und Reprints

Abstract

Purpose Incidence of early onset neurocognitive dysfunction has been reported in World Trade Center (WTC) responders. Ongoing studies are investigating the underlying etiology, as we are concerned that an underlying risk of neurodegenerative dementia may be occurring because of their stressful and neurotoxic exposures to particulate matter when they responded to the search and rescue efforts on September 11, 2001. The purpose of this study is to report preliminary results from two ongoing positron emission tomography (PET)/magnetic resonance imaging (MRI) imaging studies investigating the presence of Alzheimer's disease (AD) biomarkers, such as β-amyloid, tau, and neurodegeneration, and compare our findings to published norms.

Methods We present findings on 12 WTC responders diagnosed with either cognitive impairment (CI) or mild cognitive impairment (MCI), now at midlife, who underwent PET/MRI brain imaging as part of ongoing studies. Six responders with CI received [18F] florbetaben (FBB) to detect β-amyloidosis and six separate responders with MCI received [18F] flortaucipir (FTP) to detect tauopathy. All 12 responders underwent concomitant MRI scans for gray matter volume analysis of neurodegeneration.

Results PET analysis revealed 50% FBB and 50% of FTP scans were clinically read as positive and that 50% of FTP scans identified as consistent with Braak's stage I or II. Furthermore, one responder identified as centiloid positive for AD. Gray matter volumes from MRI analyses were compared with age/sex-matched norms (Neuroquant), identifying abnormally low cortical volumes in the occipital and temporal lobes, as well as the inferior temporal gyri and the entorhinal cortex.

Conclusion These preliminary results suggest that WTC responders with neurocognitive dysfunction may be at increased risk for a neurodegenerative dementia process as a result of their exposures at September 11, 2001.

Keywords

world trade center responders - mild cognitive impairment - PET/MRI - β-amyloid - tau - neurodegeneration

Ethics

The Institutional Review Board (IRB) of each institution (no.: 983492; no.: 1257148) approved the study protocol which included informed consent.


Data Availability

Data can be made available upon reasonable request to the corresponding author.




Publikationsverlauf

Artikel online veröffentlicht:
02. September 2022

© 2022. World Association of Radiopharmaceutical and Molecular Therapy (WARMTH). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Clouston SAP, Diminich ED, Kotov R. et al. Incidence of mild cognitive impairment in World Trade Center responders: long-term consequences of re-experiencing the events on 9/11/2001. Alzheimers Dement (Amst) 2019; 11: 628-636
    CrossrefPubMedGoogle Scholar
  • 2 Lioy PJ, Weisel CP, Millette JR. et al. Characterization of the dust/smoke aerosol that settled east of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001. Environ Health Perspect 2002; 110 (07) 703-714
    CrossrefPubMedGoogle Scholar
  • 3 Clouston S, Pietrzak RH, Kotov R. et al. Traumatic exposures, posttraumatic stress disorder, and cognitive functioning in World Trade Center responders. Alzheimers Dement (N Y) 2017; 3 (04) 593-602
    CrossrefPubMedGoogle Scholar
  • 4 Kritikos M, Gandy SE, Meliker JR, Luft BJ, Clouston SAP. Acute versus chronic exposures to inhaled particulate matter and neurocognitive dysfunction: pathways to alzheimer's disease or a related dementia. J Alzheimers Dis 2020; 78 (03) 871-886
    CrossrefPubMedGoogle Scholar
  • 5 Clouston SAP, Deri Y, Horton M. et al. Reduced cortical thickness in World Trade Center responders with cognitive impairment. Alzheimers Dement (Amst) 2020; 12 (01) e12059
    Google Scholar
  • 6 Kritikos M, Clouston SAP, Diminich ED. et al. Pathway analysis for plasma β-amyloid, tau and neurofilament light (ATN) in World Trade Center responders at midlife. Neurol Ther 2020; 9 (01) 159-171
    CrossrefPubMedGoogle Scholar
  • 7 Diminich ED, Clouston SAP, Kranidis A. et al. Chronic posttraumatic stress disorder and comorbid cognitive and physical impairments in World Trade Center responders. J Trauma Stress 2021; 34 (03) 616-627
    CrossrefPubMedGoogle Scholar
  • 8 Knopman DS, Haeberlein SB, Carrillo MC. et al. The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: perspectives from the research roundtable. Alzheimers Dement 2018; 14 (04) 563-575
    CrossrefPubMedGoogle Scholar
  • 9 Jack Jr CR, Bennett DA, Blennow K. et al; Contributors. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement 2018; 14 (04) 535-562
    Google Scholar
  • 10 Nasreddine ZS, Phillips NA, Bédirian V. et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53 (04) 695-699
    Google Scholar
  • 11 Freitas S, Simões MR, Alves L, Santana I. Montreal cognitive assessment: validation study for mild cognitive impairment and Alzheimer disease. Alzheimer Dis Assoc Disord 2013; 27 (01) 37-43
    CrossrefPubMedGoogle Scholar
  • 12 Simons JS, Spiers HJ. Prefrontal and medial temporal lobe interactions in long-term memory. Nat Rev Neurosci 2003; 4 (08) 637-648
    CrossrefPubMedGoogle Scholar
  • 13 Morris RG, Garrud P, Rawlins JN, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982; 297 (5868): 681-683
    CrossrefPubMedGoogle Scholar
  • 14 Sarnyai Z, Sibille EL, Pavlides C, Fenster RJ, McEwen BS, Toth M. Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci U S A 2000; 97 (26) 14731-14736
    CrossrefPubMedGoogle Scholar
  • 15 Buffalo EA, Reber PJ, Squire LR. The human perirhinal cortex and recognition memory. Hippocampus 1998; 8 (04) 330-339
    CrossrefPubMedGoogle Scholar
  • 16 Holdstock JS, Gutnikov SA, Gaffan D, Mayes AR. Perceptual and mnemonic matching-to-sample in humans: contributions of the hippocampus, perirhinal and other medial temporal lobe cortices. Cortex 2000; 36 (03) 301-322
    CrossrefPubMedGoogle Scholar
  • 17 Schiff HC, Johansen JP, Hou M. et al. β-adrenergic receptors regulate the acquisition and consolidation phases of aversive memory formation through distinct, temporally regulated signaling pathways. Neuropsychopharmacology 2017; 42 (04) 895-903
    CrossrefPubMedGoogle Scholar
  • 18 McGaugh JL. Memory–a century of consolidation. Science 2000; 287 (5451): 248-251
    CrossrefPubMedGoogle Scholar
  • 19 Clark IA, Mackay CE. Mental imagery and post-traumatic stress disorder: a neuroimaging and experimental psychopathology approach to intrusive memories of trauma. Front Psychiatry 2015; 6: 104
    CrossrefPubMedGoogle Scholar
  • 20 Lanius RA, Williamson PC, Boksman K. et al. Brain activation during script-driven imagery induced dissociative responses in PTSD: a functional magnetic resonance imaging investigation. Biol Psychiatry 2002; 52 (04) 305-311
    CrossrefPubMedGoogle Scholar
  • 21 Lanius RA, Williamson PC, Bluhm RL. et al. Functional connectivity of dissociative responses in posttraumatic stress disorder: a functional magnetic resonance imaging investigation. Biol Psychiatry 2005; 57 (08) 873-884
    CrossrefPubMedGoogle Scholar
  • 22 Albright J, Leyden K, Airriess C. The importance of quantitative volumetric analysis for brain MRI. Accessed April 19, 2022 at: http://www.cortechslabs.com/whitepapers
    Google Scholar
  • 23 Luo W, Airries C, Albright J. Normative database. Accessed April 19, 2022 at: http://www.cortechslabs.com/whitepapers
    Google Scholar
  • 24 Wooten DW, Guehl NJ, Verwer EE. et al. Pharmacokinetic evaluation of the tau PET radiotracer 18F-T807 (18F-AV-1451) in human subjects. J Nucl Med 2017; 58 (03) 484-491
    CrossrefPubMedGoogle Scholar
  • 25 Mishra S, Gordon BA, Su Y. et al. AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: defining a summary measure. Neuroimage 2017; 161: 171-178
    CrossrefPubMedGoogle Scholar
  • 26 Izquierdo-Garcia D, Hansen AE, Förster S. et al. An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: application to simultaneous PET/MR brain imaging. J Nucl Med 2014; 55 (11) 1825-1830
    CrossrefPubMedGoogle Scholar
  • 27 Fischl B. FreeSurfer. Neuroimage 2012; 62 (02) 774-781
    CrossrefPubMedGoogle Scholar
  • 28 Greve DN, Svarer C, Fisher PM. et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage 2014; 92: 225-236
    CrossrefPubMedGoogle Scholar
  • 29 Greve DN, Salat DH, Bowen SL. et al. Different partial volume correction methods lead to different conclusions: an (18)F-FDG-PET study of aging. Neuroimage 2016; 132: 334-343
    CrossrefPubMedGoogle Scholar
  • 30 Bullich S, Seibyl J, Catafau AM. et al. Optimized classification of 18F-florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment. Neuroimage Clin 2017; 15: 325-332
    CrossrefPubMedGoogle Scholar
  • 31 Rowe CC, Doré V, Jones G. et al. 18F-florbetaben PET beta-amyloid binding expressed in centiloids. Eur J Nucl Med Mol Imaging 2017; 44 (12) 2053-2059
    CrossrefPubMedGoogle Scholar
  • 32 Cho H, Choi JY, Hwang MS. et al. In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum. Ann Neurol 2016; 80 (02) 247-258
    CrossrefPubMedGoogle Scholar
  • 33 Ferreira D, Verhagen C, Hernández-Cabrera JA. et al. Distinct subtypes of Alzheimer's disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications. Sci Rep 2017; 7: 46263
    CrossrefPubMedGoogle Scholar
  • 34 Whitwell JL, Dickson DW, Murray ME. et al. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study. Lancet Neurol 2012; 11 (10) 868-877
    CrossrefPubMedGoogle Scholar
  • 35 Murray ME, Graff-Radford NR, Ross OA, Petersen RC, Duara R, Dickson DW. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study. Lancet Neurol 2011; 10 (09) 785-796
    CrossrefPubMedGoogle Scholar
  • 36 Holroyd S, Shepherd ML, Downs III JH. Occipital atrophy is associated with visual hallucinations in Alzheimer's disease. J Neuropsychiatry Clin Neurosci 2000; 12 (01) 25-28
    CrossrefPubMedGoogle Scholar
  • 37 El Haj M, Roche J, Jardri R, Kapogiannis D, Gallouj K, Antoine P. Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease. Neurosci Biobehav Rev 2017; 83: 713-720
    CrossrefPubMedGoogle Scholar
  • 38 Crutch SJ, Schott JM, Rabinovici GD. et al; Alzheimer's Association ISTAART Atypical Alzheimer's Disease and Associated Syndromes Professional Interest Area. Consensus classification of posterior cortical atrophy. Alzheimers Dement 2017; 13 (08) 870-884
    CrossrefPubMedGoogle Scholar
  • 39 Tan L, Zhang L, Qi R. et al. Brain structure in post-traumatic stress disorder: a voxel-based morphometry analysis. Neural Regen Res 2013; 8 (26) 2405-2414
    PubMedGoogle Scholar
  • 40 Ganis G, Thompson WL, Kosslyn SM. Brain areas underlying visual mental imagery and visual perception: an fMRI study. Brain Res Cogn Brain Res 2004; 20 (02) 226-241
    CrossrefPubMedGoogle Scholar
  • 41 Speer K, Upton D, Semple S, McKune A. Systemic low-grade inflammation in post-traumatic stress disorder: a systematic review. J Inflamm Res 2018; 11: 111-121
    CrossrefPubMedGoogle Scholar
  • 42 Hori H, Kim Y. Inflammation and post-traumatic stress disorder. Psychiatry Clin Neurosci 2019; 73 (04) 143-153
    CrossrefPubMedGoogle Scholar
  • 43 Mohlenhoff BS, O'Donovan A, Weiner MW, Neylan TC. Dementia risk in posttraumatic stress disorder: the relevance of sleep-related abnormalities in brain structure, amyloid, and inflammation. Curr Psychiatry Rep 2017; 19 (11) 89
    CrossrefPubMedGoogle Scholar
  • 44 Logue MW, van Rooij SJH, Dennis EL. et al. Smaller hippocampal volume in posttraumatic stress disorder: a multisite ENIGMA-PGC study: subcortical volumetry results from posttraumatic stress disorder consortia. Biol Psychiatry 2018; 83 (03) 244-253
    CrossrefPubMedGoogle Scholar